|
|
.
See Category: Neoplasms
See Header: Squamous cell carcinoma skin/ upper limb, including shoulder
ICD-10 (CM) Code and Descriptor
|
C44.622 |
Squamous cell carcinoma of skin of right upper limb, including shoulder
|
C44622 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 58.50%
|
20.06%
|
8.02%
|
3.91%
|
2.80%
|
1.68%
|
1.15%
|
0.92%
|
0.82%
|
0.51%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C44.622*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
7,388
|
9,441
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
2,768
|
2,773
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
1,303
|
1,306
|
|
12032
|
INTMD RPR S/A/T/EXT 2.6-7.5 |
1,210
|
1,210
|
|
11102
|
TANGNTL BX SKIN SINGLE LES |
1,137
|
1,137
|
|
11602
|
EXC TR-EXT MAL+MARG 1.1-2 CM |
1,046
|
1,061
|
|
17311
|
MOHS 1 STAGE H/N/HF/G |
932
|
967
|
|
17000
|
DESTRUCT PREMALG LESION |
706
|
706
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
668
|
18,239
|
|
11603
|
EXC TR-EXT MAL+MARG 2.1-3 CM |
623
|
635
|
|
17003
|
DESTRUCT PREMALG LES 2-14 |
564
|
1,754
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
534
|
1,955
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
512
|
516
|
|
J3010
|
FENTANYL CITRATE INJECTION |
512
|
673
|
|
17313
|
MOHS 1 STAGE T/A/L |
495
|
516
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
476
|
476
|
|
88331
|
PATH CONSLTJ SURG 1 BLK 1SPC |
440
|
594
|
|
80053
|
COMPREHEN METABOLIC PANEL |
400
|
400
|
|
11606
|
EXC TR-EXT MAL+MARG >4 CM |
392
|
397
|
|
13121
|
CMPLX RPR S/A/L 2.6-7.5 CM |
385
|
385
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C44.622 related to the following DRG Codes:
606-607
|
